ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,891.93
      -0.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Matinas Biopharma Holdings Inc (MTNB)

      7. Matinas Biopharma Holdings Inc (MTNB) Financials

      Matinas Biopharma Holdings Inc

      Matinas Biopharma Holdings Inc (MTNB)

      AMEX
      0.1692
      -0.0002
      (-0.12%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      0.1663
      -0.0029
      (-1.71%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Matinas Biopharma Holdings Inc Financial Summary

      The current MTNB market cap is 43.89M. The company's latest EPS is USD -0.0915 and P/E is -1.86.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.1M0000
      Operating Income -5.59M-6.16M-6.13M-5.89M-5.9M
      Net Income -5.51M-6.06M-6.06M-5.31M-5.82M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 90k158k33k3.19M1.1M
      Operating Income -18.92M-24.21M-24.74M-24.59M-23.77M
      Net Income -18.3M-23.24M-23.68M-21M-22.94M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 38.26M34.03M29.79M25.1M19.61M
      Total Liabilities 5.64M6.17M6.64M5.86M5.05M
      Total Equity 32.63M27.85M23.15M19.25M14.56M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 40.24M70.97M61.33M44.82M25.1M
      Total Liabilities 7.19M7.24M8.83M8.18M5.86M
      Total Equity 33.05M63.73M52.49M36.64M19.25M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.09M-6.28M-10.7M-15.28M-5.77M
      Investing 3M9.2M10.28M13.24M2M
      Financing -4k-5k-6k-7k53k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -14.09M-17.37M-15.22M-19.16M-15.28M
      Investing -6.01M-40.67M16.77M4.88M13.24M
      Financing 29.85M48.05M6.97M79k-7k

      Stats and Ratios

      Market Cap 43.89M
      Price to Earnings Ratio -1.86
      Price to Sales Ratio 38.64
      Price to Cash Ratio 8.9
      Price to Book Ratio 2.22
      Dividend Yield -

      Share Statistics

      Shares Outstanding 250.82M
      Average Volume (1 week) 956.58k
      Average Volume (1 Month) 878.06k
      52 Week Change -56.25%
      52 Week High 0.89
      52 Week Low 0.1103
      Spread (Intraday) 0.01 (5.71%)

      Company Info

      Company Name Matinas Biopharma Holdings Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.matinasbiopharma.com
      Industry pharmaceutical preparations (2834)